Back to search
Immunosuppression For Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immunosuppression For Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immunosuppression For Disease trials you may qualify forThe goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS)…
Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in part…
Liver metastases (MTS) are the main cause of death for patients affected by colorectal carcinoma (CRC) and pancreatic ductal adenocarcinoma (PDAC), thus represe…
This is a randomized controlled trial to compare the efficacy and safety of infliximab and immunosuppressives therapy alone or in combination for pediatric Croh…
Background: Severe aplastic anemia (SAA) is a rare and serious blood disorder. It causes the immune system to turn against bone marrow cells. Standard treatmen…
It is important people receiving immunosuppressive therapy are provided with the best protection against COVID-19 because they are at greater risk of severe ill…
This randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with hematologic malignancies undergoing un…
Background: * Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This cause…